193 related articles for article (PubMed ID: 33667475)
1. Distinct plasma biomarkers confirm the diagnosis of mastocytosis and identify increased risk of anaphylaxis.
Gülen T; Teufelberger A; Ekoff M; Westerberg CM; Lyberg K; Dahlén SE; Dahlén B; Nilsson G
J Allergy Clin Immunol; 2021 Sep; 148(3):889-894. PubMed ID: 33667475
[TBL] [Abstract][Full Text] [Related]
2. Mastocytosis associated with severe wasp sting anaphylaxis detected by elevated serum mast cell tryptase levels.
Biedermann T; Ruëff F; Sander CA; Przybilla B
Br J Dermatol; 1999 Dec; 141(6):1110-2. PubMed ID: 10606862
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for anaphylaxis in patients with mastocytosis.
Górska A; Niedoszytko M; Lange M; Chełmińska M; Nedoszytko B; Wasąg B; Słomiński JM; Gruchała-Niedoszytko M; Nowicki R; Jassem E
Pol Arch Med Wewn; 2015; 125(1-2):46-53. PubMed ID: 25578100
[TBL] [Abstract][Full Text] [Related]
4. Massive release of the histamine-degrading enzyme diamine oxidase during severe anaphylaxis in mastocytosis patients.
Boehm T; Reiter B; Ristl R; Petroczi K; Sperr W; Stimpfl T; Valent P; Jilma B
Allergy; 2019 Mar; 74(3):583-593. PubMed ID: 30418682
[TBL] [Abstract][Full Text] [Related]
5. Disease spectrum in patients with elevated serum tryptase levels.
Aberer E; Savic S; Bretterklieber A; Reiter H; Berghold A; Aberer W
Australas J Dermatol; 2015 Feb; 56(1):7-13. PubMed ID: 24575854
[TBL] [Abstract][Full Text] [Related]
6. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
[TBL] [Abstract][Full Text] [Related]
7. High prevalence of anaphylaxis in patients with systemic mastocytosis - a single-centre experience.
Gülen T; Hägglund H; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Jan; 44(1):121-9. PubMed ID: 24164252
[TBL] [Abstract][Full Text] [Related]
8. Added sensitivity of component-resolved diagnosis in hymenoptera venom-allergic patients with elevated serum tryptase and/or mastocytosis.
Michel J; Brockow K; Darsow U; Ring J; Schmidt-Weber CB; Grunwald T; Blank S; Ollert M
Allergy; 2016 May; 71(5):651-60. PubMed ID: 26836051
[TBL] [Abstract][Full Text] [Related]
9. The problem of anaphylaxis and mastocytosis.
Müller UR; Haeberli G
Curr Allergy Asthma Rep; 2009 Jan; 9(1):64-70. PubMed ID: 19063827
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
Schwartz LB
Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
[TBL] [Abstract][Full Text] [Related]
11. Case Report: Mastocytosis: The Long Road to Diagnosis.
Rama TA; Martins D; Gomes N; Pinheiro J; Nogueira A; Delgado L; Plácido JL; Coimbra A
Front Immunol; 2021; 12():635909. PubMed ID: 33643319
[TBL] [Abstract][Full Text] [Related]
12. Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels.
Zanotti R; Lombardo C; Passalacqua G; Caimmi C; Bonifacio M; De Matteis G; Perbellini O; Rossini M; Schena D; Busa M; Marcotulli MC; Bilò MB; Franchini M; Marchi G; Simioni L; Bonadonna P
J Allergy Clin Immunol; 2015 Jul; 136(1):135-9. PubMed ID: 25605272
[TBL] [Abstract][Full Text] [Related]
13. Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis.
Brockow K; Plata-Nazar K; Lange M; Nedoszytko B; Niedoszytko M; Valent P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33799959
[TBL] [Abstract][Full Text] [Related]
14. Risk Factor Analysis of Anaphylactic Reactions in Patients With Systemic Mastocytosis.
Gülen T; Ljung C; Nilsson G; Akin C
J Allergy Clin Immunol Pract; 2017; 5(5):1248-1255. PubMed ID: 28351784
[TBL] [Abstract][Full Text] [Related]
15. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis.
González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L
Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093
[TBL] [Abstract][Full Text] [Related]
16. The presence of mast cell clonality in patients with unexplained anaphylaxis.
Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G
Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926
[TBL] [Abstract][Full Text] [Related]
17. Oxidative stress markers are increased in patients with mastocytosis.
Gangemi S; Minciullo PL; Magliacane D; Saitta S; Loffredo S; Saija A; Cristani M; Marone G; Triggiani M
Allergy; 2015 Apr; 70(4):436-42. PubMed ID: 25630934
[TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA).
González de Olano D; de la Hoz Caballer B; Núñez López R; Sánchez Muñoz L; Cuevas Agustín M; Diéguez MC; Alvarez Twose I; Castells MC; Escribano Mora L
Clin Exp Allergy; 2007 Oct; 37(10):1547-55. PubMed ID: 17883734
[TBL] [Abstract][Full Text] [Related]
20. Hereditary alpha-tryptasemia in 101 patients with mast cell activation-related symptomatology including anaphylaxis.
Giannetti MP; Weller E; Bormans C; Novak P; Hamilton MJ; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):655-660. PubMed ID: 33465452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
